- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03013764
Diet Composition and Physical Inactivity on Insulin Sensitivity and β-cell Function
Interaction Between Diet Composition and Physical Inactivity on Insulin Sensitivity and β-cell Function
Physical inactivity results in reductions in glucose tolerance and less sensitivity to insulin. If this inactivity lasts long enough it can result in insulin resistance and type 2 diabetes. A high protein diet can reduce elevated glucose levels in individuals with type 2 diabetes. Thus the investigators are interested in establishing if during a period of inactivity if a diet modification can minimize the glucose changes normally observed with inactivity. The objective of this project is to determine if short-term high protein (HP) feeding protects against the changes in glucose levels normally observed with physical inactivity. The investigators will also examine measures of blood vessel function, blood lipid and blood pressure.
Twelve subjects will complete two 10 day study periods of reduced physical activity and will be studied before and after each of these study periods. For their testing subjects will have the following measurements: postprandial glucose responses to a mixed meal, 24 h free living blood pressure control during acute physical inactivity, blood lipids, changes in body composition, changes in circadian rhythm using skin temperature (ibutton), measurement of aerobic capacity (VO2 max), blood vessel responsiveness (flow mediated dilation -FMD) and changes in free living glucose levels (continuous glucose monitoring system (CGMS). Subjects will complete two conditions (high protein -HP vs normal protein - NP diets) in a randomized cross-over design. In the inactive phase subjects will reduce there steps to <5,000 steps/d while consuming either a HP or NP diet. Completion of the study will take 8-10 weeks.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
It is well known that insulin resistance increases the risk of cardiovascular disease and type 2 diabetes, which substantially impact mortality and morbidity and presents a significant economic burden. Energy restriction with or without exercise has been demonstrated to attenuate/reverse the development of insulin resistance and reduce the risk of cardiovascular disease and type 2 diabetes. Indeed, accumulating evidence suggests that diets high in protein may possess additional protection against the development of insulin resistance during energy restriction. Layman et al. found that a high protein diet (HP) (PRO 125 g/d) compared with an isocaloric high carbohydrate diet (HCHO) (PRO 68 g/d) resulted in greater reductions in fasting glucose and 2 h postprandial insulin levels during 16 weeks of energy restriction in overweight women. Similarly, a hypocaloric high protein diet (PRO 45% vs 20%; 21 d diet treatment) increased glucose oxidation and improved insulin sensitivity compared to an isocaloric high carbohydrate diet during a euglycemic hyperinsulinemic clamp procedure. In addition, markers of inflammation, β-cell function, and postprandial glucose and insulin levels were improved in addition to increased resting energy expenditure after 6 months of hypocaloric HP compared with HCHO diet in premenopausal women independent of weight loss. The increase in REE and improvement in adipose tissue function may be a potential mechanism by which HP diet improves β-cell function since NEFAs are lower, which may reduce lipotoxicity on the pancreas.
It is evident that physical inactivity (highlighted from bed rest studies) impairs glucose tolerance, insulin sensitivity, vascular function, and muscle protein synthesis in both healthy and obese individuals. This model of inactivity, however, is extreme and does not recapitulate the physical inactivity paradigm seen in the natural human environment. Consequently, a less extreme reduction in daily physical activity (>10,000 steps/d to ~1,500 steps/d) results in significant reductions in insulin sensitivity, glucose tolerance, and insulin-stimulated muscle Akt phosphorylation, suggesting that the impairments in insulin sensitivity and glucose tolerance precede changes in body composition. A reduction in ambulatory activity is a highly valid and translatable model to study the role of inactivity on the development of metabolic disease, as most individuals go through periods of inactivity, and it has been shown that a reduction in daily steps decreases insulin sensitivity and increases visceral adiposity. To date, no study has tested the effects of diet composition on the perturbations of physical inactivity. It is important to know if increasing protein intake mitigates the negative perturbations of reduced ambulatory activity.
Thus, the overall objective of this project is to determine the extent to which short-term high protein (HP) feeding may protect against the metabolic perturbations of physical inactivity (i.e. PPG, hyperinsulinemia, and insulin sensitivity). The investigators will also examine measures of vascular function and free living blood pressure in addition to lipemic responses (i.e. FFAs, triglycerides, cholesterol, and lipoproteins) to determine if HP diet impacts vascular function and lipemic responses during short term physical inactivity.
Trial Objectives and Purpose
The specific aims of this project include the following:
Specific Aim 1: To determine if HP diet during a period of low physical activity will lower the insulin response to a meal, and help to maintain insulin sensitivity and β-cell function during a laboratory based mixed meal test (MMT) with stable isotope tracers.
Specific Aim 2: To determine if a HP diet during a period of low physical activity will maintain glycemic control measured by continuous glucose monitoring (CGM) in healthy, recreationally active, young individuals.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Missouri
-
Columbia, Missouri, United States, 65211
- University of Missouri
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- BMI <28 kg/m2
- No known cardiovascular, kidney, or liver disease.
- No history of surgery for weight loss and weight stable for prior 3 months (weight change < 3 kg).
- Physically active individual (90 minutes of primarily whole body aerobic physical activity <3 days per week and taking greater than 10,000 steps per day)
- Between 18-45 yr of age.
- Participants who consume on average less than 18% of total calories as protein
Exclusion Criteria:
- History of alcohol use (< 20 g/day for males and > 10 g/day for females)
- Smoker.
- BMI < 28 kg/m2
- Kidney or liver disease.
- Physically inactive (completing < 75 min of whole body aerobic activity <3 times per week or obtaining <10,000 steps/day)
- Pregnant or lactating
- <18 or >45 yr of age
- High protein consumers (>20% of total daily calories as protein)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: normal protein intake
subjects will undergo 10 days of low physical activity while consuming a normal protein diet
|
subjects will undergo 10 days of low physical activity while consuming a normal protein diet
|
Experimental: high protein intake
subjects will undergo 10 days of low physical activity while consuming a high protein diet
|
subjects will undergo 10 days of low physical activity while consuming a high protein diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
glucose excursions
Time Frame: change in from baseline
|
change in from baseline
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
insulin sensitivity
Time Frame: change in from baseline
|
change in from baseline
|
blood lipids
Time Frame: change in from baseline
|
change in from baseline
|
insulin, FFA and other hormones (e.g. glucagon, adropin, etc)
Time Frame: change in from baseline
|
change in from baseline
|
endothelial function
Time Frame: change in from baseline
|
change in from baseline
|
beta cell function
Time Frame: change in from baseline
|
change in from baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- American Egg Board - 00050021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Inactivity
-
University of Alabama at BirminghamRecruitingDisability Physical | Physical InactivityUnited States
-
University of IowaNational Institute on Aging (NIA); Northeastern UniversityNot yet recruiting
-
Ludwig Boltzmann Institute for Digital Health and...RecruitingPhysical InactivityAustria
-
University of MichiganNational Institute on Aging (NIA)Recruiting
-
University of MinnesotaRecruitingPhysical InactivityUnited States
-
Brown UniversityNational Cancer Institute (NCI)Recruiting
-
Universiti Putra MalaysiaRecruitingInactivity, PhysicalPakistan
-
University of Milano BicoccaFederico II University; University of BergamoRecruitingPhysical InactivityItaly
-
Brown UniversityNational Institute of General Medical Sciences (NIGMS)Not yet recruitingPhysical InactivityUnited States
-
University of CalgaryPublic Health Agency of Canada (PHAC)Recruiting
Clinical Trials on normal protein diet
-
Assiut UniversityNot yet recruiting
-
Chang Gung Memorial HospitalCompletedIschemic Stroke | Diet, Healthy | Muscle LossTaiwan
-
Federal University of UberlandiaCompletedShift Work Type Circadian Rhythm Sleep DisorderBrazil
-
Rio de Janeiro State UniversityRio de Janeiro State Research Supporting Foundation (FAPERJ)Completed
-
Federal University of Rio Grande do SulHospital de Clinicas de Porto Alegre; Coordenação de Aperfeiçoamento de Pessoal... and other collaboratorsCompletedPolycystic Ovary SyndromeBrazil
-
Coordinación de Investigación en Salud, MexicoTerminated
-
Taichung Veterans General HospitalFresenius Kabi Taiwan Ltd.CompletedChronic Kidney DiseaseTaiwan
-
Sun Yat-sen UniversityCompleted
-
Steno Diabetes Center CopenhagenCompletedType 1 Diabetes Mellitus With Diabetic NephropathyDenmark
-
Vanderbilt UniversityCompletedCircadian Rhythms | MetabolismUnited States